selected scholarly activity
-
conferences
- Predictors of specialist palliative care access and impact on aggressiveness of end-of-life care: a population-based study of gynecologic cancer decedents in Ontario, Canada from 2006-2018. International Journal of Gynecological Cancer. A42-A42. 2024
- Patient-reported outcomes during pelvic radiation therapy: A secondary analysis on sexual function from NRG-RTOG 1203. Journal of Clinical Oncology. 2023
- 34/#806 Patterns of palliative care utilization by women with gynecologic malignancies in Ontario, Canada: a 13-year population-based retrospective analysis. International Journal of Gynecological Cancer. A40-A40. 2022
- 2022-RA-747-ESGO Quality of end-of-life care and patterns of palliative care use by women with gynaecologic malignancies in Ontario, Canada: a 13-year population-based retrospective analysis. International Journal of Gynecological Cancer. a364-a365. 2022
- Quality of end-of-life care for women with gynecologic malignancies in Ontario, Canada: A 14-year population-based retrospective analysis (132). Gynecologic Oncology. S82-S83. 2022
- Impact of Stereotactic Body Radiotherapy (SBRT) in Oligoprogressive Metastatic Disease. International Journal of Radiation Oncology Biology Physics. e479-e479. 2021
- 52: Impact of Stereotactic Body Radiotherapy (SBRT) in Oligoprogressive Metastatic Disease. Radiotherapy and Oncology. S25-S25. 2021
- PROSTATE SBRT BOOST RADIOTHERAPY (PBS TRIAL): A RANDOMIZED PHASE II TRIAL OF SBRT VERSUS CONVENTIONALLY-FRACTIONATED RADIOTHERAPY BOOST FOLLOWING PELVIC RADIOTHERAPY IN HIGH-RISK PROSTATE CANCER. Radiotherapy and Oncology. S64-S64. 2021
- A RANDOMIZED PHASE II TRIAL OF PROSTATE BOOST IRRADIATION WITH STEREOTACTIC BODY RADIOTHERAPY (SBRT) IN HIGH-RISK PROSTATE CANCER. THE PBS TRIAL. Radiotherapy and Oncology. S87-S88. 2020
- ENABLING ACCESS TO CERVCIAL CANCER RADIOTHERAPY IN UGANDA: 10 YEAR UPDATE ON ROAD TO CARE. Radiotherapy and Oncology. S79-S79. 2020
- EP618 The use of preoperative imaging in endometrial cancer: are ontario physicians following GOC guidelines?. International Journal of Gynecological Cancer. A362-A363. 2019
- Global Radiation Oncology Elective in Teaching CanMEDS Competencies. International Journal of Radiation Oncology Biology Physics. E377-E377. 2015
- 183 Can an In Vitro Assay Predict Radiation Sensitivity in Patients with Carcinoma of the Prostate?. Radiotherapy and Oncology. S53-S53. 2006
- Po‐Poster ‐ 29: Radiation‐induced apoptosis of lymphocytes to predict late toxicity from radiotherapy. Medical Physics. 2415-2415. 2005
- Sci‐AM Fri ‐ 04: Radiation induced apoptosis and chromosomal aberrations in human lymphocytes: Estimating the risks associated with radiation exposures. Medical Physics. 2417-2418. 2005
-
journal articles
- Primary Analysis of (NCT03380806) a Phase II Randomized Trial of Stereotactic Body Radiotherapy Boost Versus Conventional Fractionation External Beam Radiotherapy Boost in Unfavorable-Intermediate and High-Risk Prostate Cancer.. Prostate. 85:977-985. 2025
- Patterns of failure with 18F-DCFPyL PSMA-PET/CT in the post-prostatectomy setting A regional cohort analysis.. Journal of the Canadian Urological Association. 19:17-24. 2025
- Patient-Reported Outcomes During Pelvic Radiation Therapy: A Secondary Analysis on Sexual Function From NRG-RTOG 1203.. JCO Oncol Adv. 2:e2400088. 2025
- Stereotactic Body Radiotherapy (SBRT) vs. Conventional Fractionation External Beam Radiotherapy (EBRT) Boost for Unfavorable Intermediate and High-Risk Prostate Cancer; Early Results of PBS: A Phase II Randomized Trial (NCT03380806). International Journal of Radiation Oncology Biology Physics. 120:S126-S127. 2024
- Timing of Palliative Care, End-of-Life Quality Indicators, and Health Resource Utilization.. JAMA network open. 7:e2440977. 2024
- 163 Stereotactic Body Radiotherapy for Para-Aortic Lymph Nodes for Gynaecological Cancers. Radiotherapy and Oncology. 198:s69. 2024
- 23 Stereotactic Body Versus Conventional Fractionation External Beam Radiotherapy (EBRT) Boost for High-Risk Prostate Cancer (HR-PC); Early Results of PBS: A Phase II Randomized Trial (NCT03380806). Radiotherapy and Oncology. 198:s13-s14. 2024
- Stereotactic Ablative Radiotherapy for Gynecological Oligometastatic and Oligoprogessive Tumors. JAMA Oncology. 10:941-941. 2024
- Non-Metastatic Uterine Carcinosarcoma: A Tailored Approach or One Size Fits All?. Radiation. 4:183-191. 2024
- Disease control outcomes of stereotactic body radiation therapy or moderate hypo‐fractionation for prostate cancer: Real‐world experience at two Canadian centers. Prostate. 84:193-202. 2024
- Evaluating equity of access and predictors of minimally invasive hysterectomy for endometrial and cervical cancer from 2000 to 2017 in Ontario, Canada: A population‐based cohort study. Journal of Surgical Oncology. 129:392-402. 2024
- 114 Stereotactic Body Radiation Therapy (SBRT) and Hypo-Fractionated Radiation Therapy (HFRT) Outcomes for Low and Intermediate-Risk Prostate Cancer (PRCA): Experience at Two Ontario Centres. Radiotherapy and Oncology. 186:S53-S53. 2023
- 300 Stereotactic Radiotherapy for the Re-Treatment of Pelvic and Para-Aortic Disease in Gynecologic Cancers. Radiotherapy and Oncology. 186:S127-S128. 2023
- A two-center experience: The impact of COVID-19 on two brachytherapy programs in Ontario - virtual care, service suspension and radiation therapy workflow. Journal of Medical Imaging and Radiation Sciences. 54:436-445. 2023
- Impact of timing of palliative care initiation on end-of-life quality metrics and health resource utilization (058). Gynecologic Oncology. 176:S49-S49. 2023
- Palliative care utilization across health sectors for patients with gynecologic malignancies in Ontario, Canada from 2006 to 2018. Gynecologic Oncology. 175:169-175. 2023
- Patient-reported outcomes during pelvic radiation therapy: A secondary analysis on sexual function from NRG-RTOG 1203.. Journal of Clinical Oncology. 41:5533-5533. 2023
- Biochemical disease control outcomes of stereotactic body radiation therapy (SBRT) or moderate hypo-fractionation (HFRT) for low- and intermediate-risk prostate cancer (PrCa): Retrospective analysis of 12 years of experience at two Canadian cancer centers.. Journal of Clinical Oncology. 41:363-363. 2023
- Patterns of failure after radiotherapy (RT) in patients with prostate cancer re-staged with 18F-DCFPyL PSMA-PET: A regional cohort analysis.. Journal of Clinical Oncology. 41:45-45. 2023
- Patterns of failure with 18F-DCFPyL PSMA PET/CT in the post-prostatectomy setting: A regional cohort analysis.. Journal of Clinical Oncology. 41:309-309. 2023
- Desmoplastic small round cell tumor involving the uterine cervix: The first reported case in the literature, and brief review of gynecologic presentations. Gynecologic Oncology Case Reports. 44:101079-101079. 2022
- Disparities in the survival of endometrial cancer patients in a public healthcare system: A population-based cohort study. Gynecologic Oncology. 167:532-539. 2022
- Trends in quality indicators of end-of-life care for women with gynecologic malignancies in Ontario, Canada. Gynecologic Oncology. 167:247-255. 2022
-
Salvage radiotherapy following
HiFU : An institutional series and literature review. Journal of Medical Imaging and Radiation Oncology. 66:847-852. 2022 - Impact of stereotactic body radiotherapy (SBRT) in oligoprogressive metastatic disease. Acta Oncologica. 61:705-713. 2022
- Impact of stereotactic body radiotherapy (SBRT) in oligoprogressive metastatic disease.. Acta Oncologica. 61:705-713. 2022
- The impact of preoperative imaging on wait times, surgical approach and overall survival in endometrioid endometrial cancers. Gynecologic Oncology. 165:317-322. 2022
- 151: Prostate SBRT Boost Radiotherapy (PBS Trial): A Randomized Phase II Trial of SBRT Versus Conventionally-Fractionated Radiotherapy Boost Following Pelvic Radiotherapy in High-Risk Prostate Cancer. Radiotherapy and Oncology. 163:S64-S64. 2021
- The use of imaging in endometrial cancer prior to potential surgery: Are guidelines being followed?. Gynecologic Oncology. 161:361-366. 2021
- A pilot study of stereotactic boost for malignant epidural spinal cord compression: clinical significance and initial dosimetric evaluation. Radiation Oncology. 15:267. 2020
- 184: Enabling Access to Cervcial Cancer Radiotherapy in Uganda: 10 Year Update on Road to Care. Radiotherapy and Oncology. 150:S79-S79. 2020
- 206: A Randomized Phase Ii Trial of Prostate Boost Irradiation with Stereotactic Body Radiotherapy (SBRT) in High-Risk Prostate Cancer. The Pbs Trial. Radiotherapy and Oncology. 150:S87-S88. 2020
- A Randomized Phase II Trial of Prostate Boost Irradiation With Stereotactic Body Radiotherapy (SBRT) or Conventional Fractionation (CF) External Beam Radiotherapy (EBRT) in Locally Advanced Prostate Cancer: The PBS Trial (NCT03380806). Clinical Genitourinary Cancer. 18:e410-e415. 2020
- Biological Response of Positron Emission Tomography Scan Exposure and Adaptive Response in Humans. Dose-Response. 13:155932581561190-155932581561190. 2015
- In Reply to Dr. Azria et al.. International Journal of Radiation Oncology Biology Physics. 75:1275-1276. 2009
- Radiation-Induced Lymphocyte Apoptosis to Predict Radiation Therapy Late Toxicity in Prostate Cancer Patients. International Journal of Radiation Oncology Biology Physics. 74:1424-1430. 2009
- Individual Radiosensitivity and its Relevance to Health Physics. Dose-Response. 5:dose-response.0. 2007
- 59 Radiation — Induced apoptosis of lymphocytes to predict normal tissue late toxicity from radiotherapy. Radiotherapy and Oncology. 76:S18-S18. 2005
- Artificial neural network modeling of apoptosis in gammairradiated human lymphocytes. International Journal of Radiation Biology. 81:827-840. 2005
- 93 Radiation-induced apoptosis of lymphocytes to predict late toxicity from radiotherapy. Radiotherapy and Oncology. 72:S29-S29. 2004
-
preprints